Company Filing History:
Years Active: 2022-2024
Title: Doris Shim Siew Chen: Innovator in Antibody Research
Introduction
Doris Shim Siew Chen is a prominent inventor based in Yagoona, Australia. She has made significant contributions to the field of antibody research, particularly in the development of human antibody molecules that target CXCR2. With a total of 2 patents to her name, her work has the potential to impact therapeutic approaches in various medical conditions.
Latest Patents
Doris's latest patents include innovative human antibody molecules that immunospecifically bind to human CXCR2. These antibodies serve as potent and selective antagonists of CXCR2 functions, effectively preventing the recruitment of neutrophils into tissues without significantly depleting circulating neutrophil numbers. The patents also encompass pharmaceutical compositions, nucleic acid molecules, vectors, cells, and various uses of the disclosed antibodies.
Career Highlights
Doris is currently associated with Cephalon, Inc., where she continues to advance her research in antibody development. Her work is characterized by a commitment to improving therapeutic options for patients through innovative scientific solutions.
Collaborations
Doris has collaborated with notable colleagues, including Lynn Dorothy Poulton and Adam Clarke. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic antibodies.
Conclusion
Doris Shim Siew Chen is a trailblazer in the field of antibody research, with her innovative patents paving the way for future advancements in medical treatments. Her contributions are invaluable to the scientific community and hold promise for improving patient care.